Epigenetic changes in tumor microenvironment

Indian Journal of Cancer

Volumn 48, Issue 4, 2011, Pages 507-512

  Dey, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Carcinogenesis; epigenetics; microenvironment; stroma; tumor

Indexed keywords

BETA4 INTEGRIN; CD34 ANTIGEN; COLLAGEN; CXCL2 CHEMOKINE; DNA METHYLTRANSFERASE; ELASTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBRONECTIN; GLUTATHIONE TRANSFERASE; INTERCELLULAR ADHESION MOLECULE 1; LAMININ; MACROPHAGE ACTIVATING FACTOR; MASPIN; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE MARROW CELL; CANCER CONTROL; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CHROMATIN; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; KARYOTYPING; LEUKOCYTE; MACROPHAGE; METASTASIS; METHYLATION; MONOCYTE MACROPHAGE PRECURSOR CELL; MYOEPITHELIUM CELL; MYOFIBROBLAST; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84856862426     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.92246     Document Type: Article

References (60)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)
2. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000;60:1254-60. (Pubitemid 30151992)
3. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004;117:1495-502. (Pubitemid 38559824)
4. Barclay WW, Woodruff RD, Hall MC, Cramer SD. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 2005;146:13-8. (Pubitemid 40051716)
5. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001;61:8135-42. (Pubitemid 33091604)
6. Lund AH, Lohuizen MV. Epigenetics and cancer. Genes Dev 2004;18:2315-35. (Pubitemid 39310518)
7. Dey P. Chromatin Remodeling, Cancer and Chemotherapy. Curr Med Chem 2006;13;2909-19. (Pubitemid 44509716)
8. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53. (Pubitemid 38198742)
9. Hu M, Yao J, Cai L, Bachman KE, van den Brle F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005;37:899-905. (Pubitemid 41077119)
10. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, et al. Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 2006;98:255-61. (Pubitemid 43264709)
11. Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, et al. Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol 2007;211:410-9. (Pubitemid 46332552)
12. Fiegl H, Millinger S, Goebel G, Müller-Holzner E, Marth C, Laird PW, et al. Breast cancer DNA methylation profiles in cancer cells and tumor stroma: Association with HER-2/neu status in primary breast cancer. Cancer Res 2006;66:29-33. (Pubitemid 43166004)
13. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224-34. (Pubitemid 39331817)
14. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, Niebuhr E, et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 2003;162:391-402. (Pubitemid 36267847)
15. Isaacs JT. The biology of hormone refractory prostate cancer. Why does it develop? Uro Clin North Am 1999;26:263-73. (Pubitemid 29228223)
16. Bissell MJ, Barcellos-Hoff MH. The influence of extracellular matrix on gene expression: Is structure the message? J Cell Sci 1987;8:327-43. (Pubitemid 18041168)
17. Cunha GR, Alaird ET, Turner T, Donjaccour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract: Role of androgen, mesenchymal-epithelial interactions and growth factors. J Androl 1992;13:465-75.
18. Bissell M J, Radisky D. Putting tumors in the context. Nat Rev Cancer 2001;1:46-54.
19. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264:169-84. (Pubitemid 32989090)
20. Knudson A. "Mutation and cancer: Statistical study of retinoblastoma". Proc Natl Acad Sci USA 1971;68:820-3.
21. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res 2000;60:2562-6. (Pubitemid 30262453)
22. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002;296:920-2. (Pubitemid 34464899)
23. Wernert N, Locherbah C, Wellmann A, Behrens P, Hugel A. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 2001;21:2259-64. (Pubitemid 33054384)
24. Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 2004;64:7231-6. (Pubitemid 39372057)
25. Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 2007;297:2103-11. (Pubitemid 46798168)
26. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, Eng C, Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: Clues to tumour-microenvironment interactions. Hum Mol Genet 2001;10:1907-13. (Pubitemid 32910535)
27. Weber F, Fukino K, Sawada T, Williams N, Sweet K, Brena RM, et al. Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br J Cancer 2005;92:1922-6. (Pubitemid 40826142)
28. Fukino K, Shen L, Patocs A, Mutter GL, Eng C, Caldes T, et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet. 2006;78:961-72. (Pubitemid 43787688)
29. Paterson RF, Ulbright TM, Maclenan GT, Zhang S, Pan CX, Sweeney CJ, et al. Molecular genetic alterations in the laser capture microdissected stroma adjacent to bladder carcinoma. Cancer 2003;98:1830-6. (Pubitemid 37310224)
30. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer cell 2004;6:17-32. (Pubitemid 38903159)
31. Böcker W, Moll R, Poremba C, Holland R, Van Diest PJ, Dervan P, et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: A new cell biological concept. Lab Invest 2002;82:737-46.
32. Moses H, Yang E, Pietonpol J. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990;63:245-7.
33. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, et al. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-MSP-and HGF-mediated signaling networks, Oncogene 2005;24:5053-68. (Pubitemid 41129083)
34. Yamashita S, Takahashi S, McDonell N, Watanabe N, Niwa T, Hosoya K, et al. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Cancer Res 2008;68:2112-21. (Pubitemid 351521783)
35. Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999;39:246-61. (Pubitemid 29244499)
36. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: The missing link of tumor microenvironment. J Urol 2005;173:10-20. (Pubitemid 39627663)
37. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002;416:552-6. (Pubitemid 34288859)
38. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999;27:2291-8. (Pubitemid 29245646)
39. Girault I, Tozlu S, Lidereau R, Bieche I. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 2003;9:4415-22. (Pubitemid 37248399)
40. Agoston AT, Argani P, Yegnasubramanian S, De Marzo AM, Ansari-Lari MA, Hicks JL, et al. Increased protein sstability causes DNA methyltransferase1 dysregulation in breeast cancer. J Biol Chem 2005;280:18302-10. (Pubitemid 41389076)
41. ShiehYS, Shiah SG, Jeng HH, Lee HS, Wu CW, Chang LC. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Cancer 2005;104:1013-21.
42. Arai E, Kanai Y, Ushijima S, Fujimoto H, Mukai K, Hirohashi S. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int J Cancer 2006;119:288-96.
43. Peng DF, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kitazawa S, et al. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis in the pancreas. Carcinogenesis 2006;27:1160-8. (Pubitemid 43985431)
44. Kanai Y, Ushijima S, Nakanishi Y, Sakamoto M, Hirohashi S. Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett 2003;192:75-82 (Pubitemid 36292165)
45. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin 2008;40:643-50. (Pubitemid 352009085)
46. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 2008;130:481-94.
47. Shook D, Keller R. Mechanism, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003;120:1351-83. (Pubitemid 37421168)
48. Tamaru H, Selker EU. A histone H3 methyltransferases controls DNA methylation in Neurospora crossa. Nature 2001;414:273-83.
49. Jackson JP, Lindroth AM, Cao X, Jacobsen SE. Control of CpNpG DNA methylation by the KRYPTONITE histone H3methy transferase. Nature 2002;416:556-60. (Pubitemid 34288860)
50. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nature Rev Genet 2002;3:415-28. (Pubitemid 34587077)
51. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochem Biophys Acta 2007;1775:138-62.
52. Oza AM. Clinical development of p glycoprotein modulators in oncology. Novartis Found Symp 2002;243:103-15.
53. Choi CH. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 2005;5:30.
54. Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Gremy G, et al. Deciphering cellular states of innate tumor drug responses. Genome Biol 2006;7: R19.
55. Perez-Plasencia C, Duenas-Gonzalez A. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy? Molecular Cancer 2006;5:27.
56. Ohisson R, Kanduri C, Whitehead J, Pfeifer S, Lobanenkov V, Feinberg AP. Epigenetic variability and the evolution of human cancer. Adv Cancer Res 2003;88:145-68. (Pubitemid 36343281)
57. Sandal T, Valyi-Nagy K, Spencer VA, Folberg R, Bissell MJ, Maniotis AJ. Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by Alul restriction enzyme. Am J Pathol 2007;170:1739-49. (Pubitemid 47339317)
58. Hellebrekers DM, Castermans K, Vire E, Dings RP, Hoebers NT, Mayo KH, et al. Epigenetic regulation of tumor endothelial cell anergy: Silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 2006;66:10770-7. (Pubitemid 44876972)
59. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumors for tissue specific therapy. Nature 2004;429:629-35. (Pubitemid 38812308)
60. St Croix B, Rago C, Velculescu V, Traverso G, RomansKE, Montgomery E, et al. Genes expressed in human tumor endothelium. Science 2000;289:1197-202. (Pubitemid 30650733)